Haixi Pharmaceutical International Holdings Limited IPO
BlueMount Capital is pleased to announce that the Initial Public Offer for Haixi Pharmaceutical International Holdings Limited has opened for investors.
Key IPO Details
- Substantial increasing profits and assets with high margins
- First Chinese pharmaceutical company to be listed on the ASX
- Long-standing brand recognition with 20 years history
- High dividend payout ratio planned at 50% of NPAT, payable twice a year
- Value investment at a P/E lower than sector average on ASX and HKEX
- Plans to expand into the Australian market and intends to acquire or invest in Australian companies in the pharmaceutical sector
- China is the worlds second largest market for pharmaceuticals
The Prospectus for the offer and a Company Presentation can be obtained via:
Open Date: 21 July 2017
Close Date: 27 October 2017
Minimum Investment A$ 2,000